NCT07317297

Extracorporeal Shockwave Therapy in the Treatment of Peyronie's Disease

• Status: Recruiting
• Phase: N/A
• Study type: Interventional
• Enrollment: 50 (estimated)
• Sponsor: Uskudar University · Academic / Other
• Sex: Male
• Age: 18 Years – 65 Years
• Healthy volunteers: Accepted

Summary

Investigation of the effectiveness of extracorporeal shock wave therapy in the treatment of Peyronie's disease.

Detailed description

The study is designed as a single-center, prospective clinical trial. Participants will be selected from among patients who present to the clinic and are diagnosed with stable stage Peyronie's disease. All participants who meet the eligibility criteria and provide written consent will undergo a standard Extracorporeal Shockwave Therapy protocol. All participants will be evaluated before and after treatment using the International Erectile Function Index-5 and the Quality of Life Questionnaire short form. The results will be statistically analyzed and interpreted.

Conditions

• Peyronie Disease

Interventions

Type	Name	Description
OTHER	Extracorporeal Shockwave Therapy	Extracorporeal Shockwave Therapy will follow a standard protocol. The treatment is planned as a total of 8 sessions (3000 pulses per session, 2.5 bar pressure, 15 Hz frequency) twice a week using a radial shockwave device. Focusing will be done on the penile shaft via gel according to the plaque localization, and shock waves will be applied to the plaque area.
OTHER	control	patients receiving normal routine pharmacological treatment without any special intervention

Timeline

• Start date: 2026-01-10
• Primary completion: 2026-02-15
• Completion: 2026-03-30
• First posted: 2026-01-05
• Last updated: 2026-01-16

Locations

1 site across 1 country: Azerbaijan